Structures by: Velikodny Y. A.
Total: 21
Bis(4'-(4'''-benzo-15-crown-5)-methyloxy-2,2':6',2''- terpyridine)nickel(ii) bis(hexafluorophosphate) ethanol disolvate monohydrate
C60H62NiN6O12,2(PF6),2(C2H6O),H2O
Dalton Transactions (2009) 14 2482-2489
a=12.801(2)Å b=20.582(2)Å c=25.813(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(4'-(4'''-benzo-15-crown-5)-methyloxy-2,2':6',2''- terpyridine)cobalt(ii) bis(hexafluorophosphate) trihydrate
C60H62CoN6O12,2(PF6),3(H2O)
Dalton Transactions (2009) 14 2482-2489
a=12.636(2)Å b=20.828(2)Å c=25.056(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(4'-(4'''-benzo-15-crown-5)-methyloxy-2,2':6',2''- terpyridine) copper(ii) bis(hexafluorophosphate)
C60H62CuN6O12,2(PF6)
Dalton Transactions (2009) 14 2482-2489
a=12.618(2)Å b=12.557(2)Å c=39.689(4)Å
α=90.00° β=97.969(17)° γ=90.00°
Bis(4'-(4'''-benzo-15-crown-5)-methyloxy-2,2':6',2''- terpyridine)zinc(ii) bis(hexafluorophosphate) trihydrate
C60H62N6O12Zn,2(PF6),3(H2O)
Dalton Transactions (2009) 14 2482-2489
a=12.679(2)Å b=20.891(2)Å c=25.303(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(4'-(4'''-benzo-15-crown-5)-methyloxy-2,2':6',2''- terpyridine) cobalt(ii) bis(thiocyanate)
C60H62CoN6O12,2(CNS)
Dalton Transactions (2009) 14 2482-2489
a=10.654(2)Å b=16.644(4)Å c=8.9540(11)Å
α=94.66(2)° β=101.42(2)° γ=78.65(2)°
(4'-(4'''-Benzo-15-crown-5-sodium thiocyanate)-methyloxy- 2,2':6',2''-terpyridine)
C31H31N4NaO6S
Dalton Transactions (2009) 14 2482-2489
a=18.643(3)Å b=9.4581(11)Å c=18.524(3)Å
α=90.00° β=109.351(14)° γ=90.00°
((4'-(4'''-Benzo-15-crown-5-sodium thiocyanate)-methyloxy- 2,2':6',2''-terpyridine) (4'-(4'''-benzo-15-crown-5-sodium dithiocyanate)-methyloxy-2,2':6',2''-terpyridine)) copper(ii) thiocyanate acetonitrile
C63H62CuN9Na2O12S3,CNS,C2H3N
Dalton Transactions (2009) 14 2482-2489
a=12.674(2)Å b=12.833(2)Å c=13.256(3)Å
α=67.047(11)° β=62.366(11)° γ=87.686(12)°
4-(2,5,8,11,14-Pentaoxadicyclo[13.4.0]nonadeca-15,17,19-trien-17-yloxy)-\ 2,2':6',2''-terpyridine
C29H29N3O6
Acta Crystallographica Section E (2008) 64, 1 o225-o225
a=58.347(11)Å b=33.712(3)Å c=5.3211(8)Å
α=90.00° β=90.00° γ=90.00°
Lead cadmium vanadate garnet
Cd2O12Pb2.63V3
Acta Crystallographica Section C (2007) 63, 7 i40-i42
a=13.1857(5)Å b=13.1857(5)Å c=13.1857(5)Å
α=90.00° β=90.00° γ=90.00°
Zoledronic acid
C5H10N2O7P2
Acta Crystallographica Section C (2013) 69, 3 263-266
a=8.4217(13)Å b=8.6039(11)Å c=8.1818(12)Å
α=92.778(16)° β=112.415(17)° γ=116.072(19)°
Zoledronic acid
C5H10N2O7P2
Acta Crystallographica Section C (2013) 69, 3 263-266
a=6.8162(12)Å b=10.6307(11)Å c=13.9240(14)Å
α=90.00° β=96.954(18)° γ=90.00°
Afobazole
C15H23N3O2S2,2(Cl)
Acta Crystallographica Section C (2013) 69, 3 299-302
a=14.4952(15)Å b=16.5419(19)Å c=7.9715(8)Å
α=90.00° β=90.858(15)° γ=90.00°
Bis[4'-(4'''-benzo-15-crown-5)-methyloxy-2,2':6',2''-terpyridine]cadmium(II) bis(hexafluoridophosphate) trihydrate
C60H62CdN6O122,2(F6P),3(H2O)
Acta Crystallographica Section E (2009) 65, 11 m1349-m1350
a=12.720(3)Å b=21.101(3)Å c=24.795(5)Å
α=90.00° β=90.00° γ=90.00°
Carvedilol dihydrogen phosphate hemihydrate
C24H27N2O4,H2PO4,0.5(H2O)
Acta Crystallographica Section E (2009) 65, 8 o2020-o2021
a=26.600(2)Å b=12.3767(12)Å c=16.5101(15)Å
α=90.00° β=106.662(11)° γ=90.00°
Carvedilol dihydrogen phosphate isopropanol solvate
C24H27N2O4,H2PO4,C3H8O
Acta Crystallographica Section E (2010) 66, 3 o613
a=11.5516(11)Å b=16.6523(19)Å c=7.8643(8)Å
α=95.404(15)° β=94.635(16)° γ=71.247(14)°
Clopidogrel hydrogen sulfate
C16H17ClNO2S,HSO4
Acta Crystallographica Section E (2010) 66, 8 o2101-o2102
a=10.4315(12)Å b=15.3345(18)Å c=12.6320(16)Å
α=90.00° β=113.28(2)° γ=90.00°
Sodium Vanadyl Phosphate
Na4O9P2V
Chemistry of Materials (2004)
a=16.0068(15)Å b=14.5129(8)Å c=7.0231(5)Å
α=90° β=90° γ=90°
2,7-Bis[2-(diethylamino)ethoxy]-9-fluorenone dihydrochloride trihydrate
C25H36N2O32,2(Cl),3(H2O)
Crystal Growth & Design (2012) 12, 12 6118
a=17.7102(19)Å b=13.3601(17)Å c=12.1598(16)Å
α=90.00° β=96.39(2)° γ=90.00°
2,7-Bis[2-(diethylamino)ethoxy]-9-fluorenone dihydrochloride
C25H36N2O32,2(Cl)
Crystal Growth & Design (2012) 12, 12 6118
a=18.7680(17)Å b=19.6955(19)Å c=6.9450(11)Å
α=90.00° β=95.096(18)° γ=90.00°
Afobazole
C15H23N3O2S2,2(Cl)
Acta Crystallographica Section C (2013) 69, 3 299-302
a=9.7910(11)Å b=18.2689(19)Å c=10.5687(12)Å
α=90.00° β=103.225(17)° γ=90.00°
2,7-Bis[2-(diethylamino)ethoxy]-9-fluorenone dihydrochloride
C25H36N2O32,2(Cl)
Crystal Growth & Design (2012) 12, 12 6118
a=15.7674(18)Å b=13.3128(15)Å c=12.2800(14)Å
α=90.00° β=95.71(2)° γ=90.00°